11 recruiting. 11 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Recruiting 11 |
| Phase 1 | 1 | Recruiting 1 |
Follow Impulsive Behavior: new trials by email Literature Review of Impulsive Behavior trials Research Report on Impulsive Behavior
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multi-Site Trial of Tirzepatide for Smoking Cessation Tirzepatide, Placebo - Smoking Cessation, Smoking Behaviors | Phase 2 | Recruiting | University of Southern California | 300 | 2026-06-05 | 2026-07-17 |
| Accelerated dTMS Smoking Cessation Bilateral deep accelerated repetitive transcranial magnetic stimulation - Tobacco Use Disorder, Addiction Nicotine | Phase 2 | Recruiting | Waypoint Centre for Mental Health Care | 40 | 2026-02-24 | 2026-04-21 |
| Tirzepatide for Alcohol Use Disorder Tirzepatide, Placebo injections - Alcohol Use Disorder, Obesity and Overweight | Phase 2 | Recruiting | University of Southern California | 42 | 2025-10-06 | 2025-10-14 |
| Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder LDX-01 plus TAU, Placebo plus TAU - Methamphetamine Abuse, Methamphetamine-dependence | Phase 2 | Recruiting | Centre hospitalier de l'Université de Montréal (CHUM) | 80 | 2025-07-18 | 2026-02-23 |
| GLP-1R Agonist Treatment for Opioid Use Disorder Semaglutide Pen Injector, Placebo - Opioid Use Disorder, Opioid Abuse and Addiction | Phase 2 | Recruiting | Milton S. Hershey Medical Center | 200 | 2025-01-27 | 2026-08-28 |
| Ketamine for Combined Depression and Alcohol Use Disorder Ketamine Hydrochloride, Midazolam Hydrochloride - Depression, Alcohol Use Disorder | Phase 1 / Phase 2 | Recruiting | University Hospital of North Norway | 34 | 2025-01-20 | 2026-06-23 |
| Serotonin Control of Impulsivity in Tourette Disorder Administration of a PET radiotracer - Tourette Disorder | Phase 2 | Recruiting | Hospices Civils de Lyon | 25 | 2024-09-24 | 2024-12-04 |
| Evaluating Tetrahydrocannabinol as an Adjunct to Opioid Agonist Therapy Aurora 1:1 Drops (Indica), Placebo - Opioid Use Disorder, Methadone | Phase 2 | Recruiting | BC Centre on Substance Use | 24 | 2024-05-23 | 2025-02-17 |
| MDMA for Co-occurring PTSD and OUD After Childbirth MDMA Assisted Therapy - Stress Disorders, Post-Traumatic, Opioid Use Disorder | Phase 2 | Recruiting | University of New Mexico | 15 | 2024-04-16 | 2026-03-16 |
| Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users Treatment as Usual plus Placebo, Treatment as Usual plus Placebo plus Contingency Management, Treatment as Usual plus lisdexamfetamine (LDX-01) - Methamphetamine Abuse, Methamphetamine-dependence | Phase 2 | Recruiting | Centre hospitalier de l'Université de Montréal (CHUM) | 440 | 2023-12-05 | 2026-02-05 |
| Cannabis' Impact on Alcohol Consumption THC-dominant cannabis, CBD-dominant cannabis, Cannabis placebo - Alcohol Drinking, Cannabis Use | Phase 2 | Recruiting | Brown University | 350 | 2023-03-16 | 2026-10-05 |
Behavior, Addictive (10) · Substance-Related Disorders (4) · Alcoholism (3) · Opioid-Related Disorders (3) · Marijuana Abuse (2) · Smoking Cessation (2) · Alcohol Drinking (1) · Chemically-Induced Disorders (1) · Depression (1) · Harm Reduction (1) · Mental Disorders (1) · Narcotic-Related Disorders (1) · Obesity (1) · Overweight (1)
Behavior (11) · Compulsive Behavior (10) · Mental Disorders (10) · Chemically-Induced Disorders (9) · Substance-Related Disorders (6) · Alcohol-Related Disorders (3) · Health Behavior (2) · Narcotic-Related Disorders (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Basal Ganglia Diseases (1) · Behavioral Symptoms (1) · Body Weight (1) · Brain Diseases (1)
Tirzepatide (2) · Ethanol (1) · Ketamine (1) · Lisdexamfetamine Dimesylate (1) · Midazolam (1) · Therapeutics (1) · semaglutide (1)
Centre hospitalier de l'Université de Montréal (CHUM) (2) · University of Southern California (2) · BC Centre on Substance Use (1) · Brown University (1) · Hospices Civils de Lyon (1) · Milton S. Hershey Medical Center (1) · University Hospital of North Norway (1) · University of New Mexico (1) · Waypoint Centre for Mental Health Care (1)
United States (5) · Canada (4) · France (1) · Norway (1)
Andreas W Blomkvist, M.D. (1) · Bernard Le Foll, MD, PhD, MCFP (AM) FCAHS (1) · Didier Jutras-Aswad (1) · Didier Jutras-Aswad, MD (1) · Hadya Khawaja, MS, CIP (1) · Jane Metrik, PhD (1) · Jennifer Nyland, PhD (1) · M Eugenia Socias, MD, MSc. (1)
PMID 15734224, PMID 25563446, PMID 25784600, PMID 27010975, PMID 30091969, PMID 30944474, PMID 31065731, PMID 31681040, PMID 32098487, PMID 33601929, PMID 33972795, PMID 40233849, PMID 40502777, PMID 41168808
2023 (1), 2025 (1), R01AA029711 (1), R21AA031892 (1), U01DA064384 (1), UH3DA050325 (1)